Compare AES & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AES | TXG |
|---|---|---|
| Founded | 1981 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Laboratory Analytical Instruments |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6B | 9.3B |
| IPO Year | 1996 | 2019 |
| Metric | AES | TXG |
|---|---|---|
| Price | $14.93 | $56.11 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 17 |
| Target Price | $15.00 | ★ $68.14 |
| AVG Volume (30 Days) | ★ 8.1M | 3.0M |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.72% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | ★ 2.04 | N/A |
| Revenue | ★ $12,233,000,000.00 | $245,893,000.00 |
| Revenue This Year | $7.93 | N/A |
| Revenue Next Year | $1.78 | $11.72 |
| P/E Ratio | $7.31 | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $13.28 | $15.18 |
| 52 Week High | $17.65 | $102.81 |
| Indicator | AES | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 51.13 | 37.75 |
| Support Level | $14.83 | $18.13 |
| Resistance Level | $15.03 | $63.82 |
| Average True Range (ATR) | 0.05 | 6.09 |
| MACD | -0.00 | -1.09 |
| Stochastic Oscillator | 45.45 | 9.45 |
AES is a global power company that operates in 15 countries. Its generation portfolio totals over 32 gigawatts, including renewable energy (50%), gas (32%), coal (16%), and oil (2%). AES owns a majority stake and operates six electric utilities, distributing power to more than 2.5 million customers.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).